Market Capitalization

A public company is offering a volatile mix of OpenAI, Worldcoin, and MrBeast. We deconstruct the high-risk, high-reward strategy behind its unique treasury.

Scienture Holdings' Arbli™ just gained 12.5M covered lives. It's not about the $219M market, but the overlooked patients who can't swallow pills.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

As fusion startup Avalanche Energy hits solar-core temperatures, its new CFO hire signals a pivotal shift from pure science to serious commercial ambition.

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

A Taipei delegation at BIO 2026 signals Taiwan's strategic pivot from manufacturing to R&D, seeking global partners for its late-stage drugs and platforms.

A DoW contract for in-orbit refueling thrusts Quantum Space into the spotlight, promising to redefine space warfare and ignite the orbital logistics economy.

With a new 77.6M tonne estimate, NVRO Metals is not just building a mine but a tech-driven hub poised to reshape Australia's critical minerals supply chain.

With a fresh $260M, Dream is building AI for nations to own. But as governments rush for digital autonomy, are we creating a new digital iron curtain?

Bitget's listing of Bluwhale AI isn't just another token. It's a test case for AI-driven credit in Web3 and a key move in the exchange's ambitious strategy.

A new report projects the wellness market will hit $12.9T by 2031. This isn't just about yoga mats; it's a tech-fueled, Asia-led economic realignment.

MotoGP's massive debt repricing reduces costs by millions, showcasing Liberty Media's proven strategy to optimize sports assets and fuel future performance.

Beyond a trade show, SIAL Guangzhou 2026 is China's strategic bid to become Asia's food larder, leveraging its manufacturing might to redefine supply chains.

CONMED appoints John Gallagher, a seasoned MedTech CFO, to navigate market headwinds and drive a new chapter of financial performance and shareholder value.

With a $110M boost, Nyxoah is bringing its innovative, battery-free sleep apnea device to the US. Is this the disruption patients have been waiting for?

A look inside Mingteng International's complex financing deal and its push to fund its role in the booming, competitive world of new energy vehicle parts.

A new $50.6M supportive housing project in Chilliwack opens its doors, but behind the celebration lies a story of massive costs and simmering local frustration.

Sol de Janeiro and the Washington Spirit's new deal is more than a sponsorship. It’s a blueprint for a future where brand, athlete, and fan share an identity.

AB Science has secured a US patent until 2042 for masitinib, a targeted therapy for advanced prostate cancer, offering new hope where few options exist.